Literature DB >> 22133749

Acute brucellosis with myelodysplastic syndrome presenting as pancytopenia and Fever of unknown origin.

Jun-Jie Li1, Zi-Ke Sheng, Sheng Tu, Sheng Bi, Xiao-Min Shen, Ji-Fang Sheng.   

Abstract

OBJECTIVE: To report a rare case of brucellosis with myelo-dysplastic syndrome (MDS). CLINICAL PRESENTATION AND INTERVENTION: A 70-year-old woman presented with pancytopenia and fever of unknown origin (FUO). The initial diagnosis was brucellosis; the woman was treated with doxycycline and rifampin against Brucella melitensis but was later diagnosed as suffering from MDS. She was immediately transferred to the Department of Hematology for further evaluation.
CONCLUSION: This study highlights the rarity of brucellosis with MDS, and we recommend that brucellosis with MDS be considered in patients presenting with pancytopenia and FUO.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22133749     DOI: 10.1159/000333698

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  4 in total

1.  Unusual Maculopapular Rash on the Scalp of a Patient with Mediterranean Spotted Fever.

Authors:  Ivan Baltadzhiev; Nedialka Popivanova
Journal:  Med Princ Pract       Date:  2018-12-03       Impact factor: 1.927

2.  Brucellosis causing bone marrow aplasia in an 11-year-old patient with complete recovery after treatment.

Authors:  Nour Youssef; Yolla Youssef; Dolly Noun; Miguel Abboud; Ghassan Dbaibo
Journal:  IDCases       Date:  2022-06-15

3.  A man with recurrent fever, arthritis, and rashes-brucellosis? A case report.

Authors:  Wen Wang; Xu Lu; Chengbo Li; Myong Jun Ri; Wei Cui
Journal:  BMC Infect Dis       Date:  2020-01-07       Impact factor: 3.090

4.  Liver tuberculosis presenting as an uncommon cause of pyrexia of unknown origin: positron emission tomography/computed tomography identifies the correct site for biopsy.

Authors:  Hai-Ying Yu; Ji-Fang Sheng
Journal:  Med Princ Pract       Date:  2014-01-15       Impact factor: 1.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.